1 / 8

Influenza Vaccines Market Trends and Forecast

The influenza vaccines market was valued at US$ 7,478.53 million in 2021 and it is expected to grow with a CAGR of 7.4% from 2022 to 2028<br>

Shahbazs
Télécharger la présentation

Influenza Vaccines Market Trends and Forecast

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Influenza Vaccines Market Global Analysis and Forecast to 2028 Published Date : Jul 2022 Email: sales@theinsightpartners.com

  2. Email: sales@theinsightpartners.com Report Studies  Influenza Vaccines Market Forecast to 2028 - COVID-19 Impact and Global Analysis By Vaccine Type (Quadrivalent Vaccines and Trivalent Vaccines), Virus Type (Influenza Virus Type A and Influenza Virus Type B), Technology (Egg-based and Cell-based), and Route of Administration (Injection and Nasal Spray) 2

  3. Email: sales@theinsightpartners.com Influenza Vaccines Market Overview  The Influenza Vaccines market is expected to grow from US$ 7,478.53 million in 2021 to US$ 12,272.49 million by 2028; it is expected to register a CAGR of 7.4% from 2022 to 2028.  Influenza is a contagious respiratory infection caused due to influenza virus. Influenza is noticed by fever, cough, muscle and joint pain, headache, and severe weakness. Illness due to influenza varies from mild to severe, sometimes leading to death. According to the World Health Organization (WHO), 2018, influenza cases related hospitalization ranges from 3-5 million cases for severe illness, whereas deaths related to influenza are about 290,000 to 650,000. 3

  4. Email: sales@theinsightpartners.com Key Segment Market Segment By Type:-  By Vaccine Type (Quadrivalent Vaccines and Trivalent Vaccines)  By Virus Type (Influenza Virus Type A and Influenza Virus Type B)  By Technology (Egg-based and Cell-based)  By Route of Administration (Injection and Nasal Spray) Download Sample Here 4

  5. Email: sales@theinsightpartners.com $50,000 Influenza Vaccines Market Value $40,000 $30,000 CAGR of 7.4% $20,000 (2022 - 2028) $10,000 $0 20XX 20XX 20XX 20XX 20XX Download Sample 5

  6. Email: sales@theinsightpartners.com Company Profiles  Moderna, Inc.  SEQIRUS  Sanofi  GlaxoSmithKline plc.  Hualan Biological Engineering Inc.  Emergent BioSolutions Inc.  Mitsubishi Chemical Group Corporation  Serum Institute of India Pvt. Ltd  MYLAN N.V.  AstraZeneca Download Sample Here 6

  7. Email: sales@theinsightpartners.com By Geography  North America (the US, Canada, and Mexico)  Europe (the UK, Germany, France, Italy, Spain, and the Rest of Europe)  Asia Pacific (China, Japan, India, Australia, South Korea, and the Rest of Asia Pacific)  Middle East & Africa (the UAE, Saudi Arabia, South Africa, and the Rest of Middle East & Africa)  South & Central America (Brazil, Argentina, and the Rest of South & Central America). 7

  8. THANK YOU! Phone : +1-646-491-9876 E-Mail : sales@theinsightpartners.com

More Related